Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Russia aims to point its ICBMs at the asteroid Apophis in 2036

Add as a preferred source on Google

Russian scientists are planning to tweak their ICBMs (intercontinental ballistic missiles) to target near-earth objects (NEOs), according to a report by news agency TASS. The news came from Sabit Saitgarayev, the leading researcher at the Makeyev Rocket Design Bureau. The projectiles could be aimed at meteorites measuring 20-50 meters in size.  A meteorite is a chunk of debris that can originate from a sun-orbiting asteroid and survive the trip through the atmosphere to reach Earth’s surface.

The scientists plan to test their missiles on the asteroid 99942 Apophis, which Saitgarayev believes may pass “dangerously close” to Earth in 2036. There is a general consensus as to this expected close encounter, though NASA has “effectively ruled out the possibility” of an impact.

Recommended Videos

The lead scientist explains the reasoning behind his team’s work. “Most rockets work on boiling fuel,” Saitgarayev says. “Their fueling begins 10 days before the launch and, therefore, they are unfit for destroying meteorites similar to the Chelyabinsk meteorite in diameter, which are detected several hours before coming close to the Earth. For this purpose, intercontinental ballistic missiles can be used, which requires their upgrade.”

Modifying the solid-fueled ICBMs will require several million dollars and permission from the authorities. These are weapons of war, after all. It is unclear whether or not this project will ever come to fruition, though the work has already begun.

The Makeyev Design Bureau was established on December 16, 1947. The company specialized in developing long-rockets designed by the OKB-1 (Experimental Design Bureau), which was led by pioneering rocket designer Sergei Korolov. It was under Korolov’s direction that Russia launched the first artificial Earth satellite, Sputnik 1, in 1957, and put the first man in space in 1961. In the mid-1950s, Maketev OKB began developing submarine-launched ballistic missiles. Today, its rockets are used to launch Russian satellites into space.

Albert Khoury
Former Weekend Editor
Al started his career at a downtown Manhattan publisher, and has since worked with digital and print publications. He's…
Intelligent UI turns ChatGPT answers into interactive tools while GPT-6 rolls out to a broader audience 
Plain text answers just got a very interactive rival.
Intelligent UI in ChatGPT.

Would you rather read instructions for splitting a dinner bill or tap a bill splitter and let it do the math? I'd pick the latter. 

OpenAI's SOl-6 rollout, starting October 7, 2026, adds Intelligent UI. Basically, it lets the chatbot assemble interactive answers instead of replying in plain text.

Read more
Checking body medication levels may now be as easy as sucking on a peach-flavoured lollipop
Forget the clinic swab; this lollipop wants a lick
Lollylab

Checking your body’s medication levels is usually no one’s idea of fun. Now researchers are trying to change that with Lollylab, a candy-coated, lollipop-like device that can collect saliva and measure levels of acetaminophen in under two minutes.

The prototype created by researchers whose work was published in ACS Sensors transforms a familiar object into a miniature testing device. In a pilot study, six adults ingested the peach-flavored Lollylab before and one hour after a standard 650-milligram dose of acetaminophen. The device repeatedly detected the pain reliever in their saliva, and participants reported it was more comfortable and easier to use than traditional saliva swabs.

Read more
A US state just approved an AI doctor. For now, it’ll only prescribe acne cures.
Aside from acne, Nolla's AI can also handle redness, fine lines and wrinkles, hyperpigmentation and dark spots, and under-eye bags.
Nolla Derm AI doctor app.

The first AI doctor is here. Despite all the skepticism and risks associated with AI models going haywire, the state of Utah just approved Nolla Health, a company that is providing an AI healthcare expert capable of writing prescriptions without any human in the chain. For now, it will only write acne prescriptions for Utah residents over 18 years of age, willing to pay a token monthly subscription fee that's lighter than your Spotify bill.

The big push here is that the Nolla Derm app will reduce the costs of medical consultation, save users the hassle of clinic visits, and take out the problem of waitlisting from the entire healthcare equation. “Unlike telehealth platforms that use AI only to collect information before handing patients off to clinicians, Nolla's AI system is designed to independently issue initial prescriptions within tightly defined, physician-approved treatment protocols,” writes the company. 

Read more